K Pharma (TSE:4896) Other Current Liabilities : 円61 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is K Pharma Other Current Liabilities?

K Pharma's other current liabilities for the quarter that ended in Mar. 2024 was 円61 Mil.

K Pharma's quarterly other current liabilities increased from Sep. 2023 (円36 Mil) to Dec. 2023 (円90 Mil) but then declined from Dec. 2023 (円90 Mil) to Mar. 2024 (円61 Mil).

K Pharma's annual other current liabilities increased from Dec. 2021 (円20 Mil) to Dec. 2022 (円22 Mil) and increased from Dec. 2022 (円22 Mil) to Dec. 2023 (円90 Mil).

K Pharma Other Current Liabilities Historical Data

The historical data trend for K Pharma's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Other Current Liabilities Chart

K Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Other Current Liabilities

K Pharma Quarterly Data
	Dec21	Dec22	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial			-	-	-	-	-

K Pharma Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

K Pharma Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of K Pharma's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

K Pharma (TSE:4896) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032

Website

https://en.kpharma.co.jp

K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines